Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

740 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of probiotics, Bifidobacterium bifidum G9-1, on gastrointestinal symptoms in patients with type 2 diabetes mellitus: study protocol for open-label, single-arm, exploratory research trial (Big STAR study).
Hashimoto Y, Nakajima H, Hata S, Miyoshi T, Hosomi Y, Majima S, Nakanishi N, Senmaru T, Osaka T, Okada H, Ushigome E, Hamaguchi M, Asano M, Yamazaki M, Fukui M. Hashimoto Y, et al. Among authors: hata s. J Clin Biochem Nutr. 2020 Nov;67(3):223-227. doi: 10.3164/jcbn.20-100. Epub 2020 Sep 30. J Clin Biochem Nutr. 2020. PMID: 33293761 Free PMC article.
Effects of probiotic Bifidobacterium bifidum G9-1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open-label, single-arm, exploratory research trial.
Hata S, Nakajima H, Hashimoto Y, Miyoshi T, Hosomi Y, Okamura T, Majima S, Nakanishi N, Senmaru T, Osaka T, Okada H, Ushigome E, Hamaguchi M, Asano M, Yamazaki M, Fukui M. Hata S, et al. J Diabetes Investig. 2022 Mar;13(3):489-500. doi: 10.1111/jdi.13698. Epub 2021 Nov 15. J Diabetes Investig. 2022. PMID: 34665938 Free PMC article. Clinical Trial.
Home-measured pulse pressure is a predictor of cardiovascular disease in type 2 diabetes: The KAMOGAWA-HBP study.
Takegami M, Ushigome E, Hata S, Yoshimura T, Kitagawa N, Hasegawa G, Tanaka T, Ohnishi M, Tsunoda S, Yokota I, Ushigome H, Asano M, Hamaguchi M, Yamazaki M, Fukui M. Takegami M, et al. Among authors: hata s. Nutr Metab Cardiovasc Dis. 2022 Oct;32(10):2330-2337. doi: 10.1016/j.numecd.2022.08.006. Epub 2022 Aug 11. Nutr Metab Cardiovasc Dis. 2022. PMID: 36100493 Free article.
Impact of sustained hypertension on new cardiovascular events in patients with type 2 diabetes: KAMOGAWA-HBP study.
Yoshimura T, Ushigome E, Hata S, Takegami M, Hasegawa G, Tanaka T, Tsunoda S, Ohnishi M, Yokota I, Ushigome H, Kitagawa N, Asano M, Hamaguchi M, Yamazaki M, Fukui M. Yoshimura T, et al. Among authors: hata s. J Clin Hypertens (Greenwich). 2022 Dec;24(12):1561-1567. doi: 10.1111/jch.14596. Epub 2022 Nov 15. J Clin Hypertens (Greenwich). 2022. PMID: 36378544 Free PMC article.
Reasons for Discontinuing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes in Real-World Settings: The KAMOGAWA-A Study.
Saijo Y, Okada H, Hata S, Nakajima H, Kitagawa N, Okamura T, Osaka T, Kitagawa N, Majima S, Senmaru T, Ushigome E, Nakanishi N, Hamaguchi M, Fukui M. Saijo Y, et al. Among authors: hata s. J Clin Med. 2023 Nov 9;12(22):6993. doi: 10.3390/jcm12226993. J Clin Med. 2023. PMID: 38002608 Free PMC article.
740 results